Corient Private Wealth
EW icon

Corient Private Wealth’s Edwards Lifesciences EW Stock Holding History

Corient Private Wealth’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6M Buy
250,101
+227,947
+1,029% +$19.1M 0.03% 381
2026
Q1 		$1.77M Sell
22,154
-77,897
-78% -$6.42M ﹤0.01% 1330
2025
Q4 		$8.55M Buy
100,051
+17,144
+21% +$1.41M 0.01% 602
2025
Q3 		$6.45M Buy
82,907
+6,994
+9% +$546K 0.01% 635
2025
Q2 		$5.94M Sell
75,913
-10,961
-13% -$817K 0.01% 652
2025
Q1 		$6.3M Sell
86,874
-7,192
-8% -$515K 0.01% 625
2024
Q4 		$6.96M Sell
94,066
-13,886
-13% -$972K 0.01% 608
2024
Q3 		$7.12M Sell
107,952
-32,830
-23% -$2.39M 0.01% 654
2024
Q2 		$13M Sell
140,782
-4,811
-3% -$426K 0.02% 468
2024
Q1 		$13.9M Buy
145,593
+7,762
+6% +$652K 0.02% 459
2023
Q4 		$10.5M Sell
137,831
-13,440
-9% -$935K 0.02% 506
2023
Q3 		$10.5M Buy
151,271
+761
+0.5% +$61.2K 0.02% 467
2023
Q2 		$14.2M Buy
150,510
+68,667
+84% +$5.97M 0.03% 410
2023
Q1 		$6.77M Buy
81,843
+2,443
+3% +$192K 0.02% 511
2022
Q4 		$5.95M Buy
+79,400
New +$6.12M 0.02% 459

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Corient Private Wealth's EW Position: Q2 2026 in Review

Corient Private Wealth increased its Edwards Lifesciences (EW) stake by 1,029% in Q2 2026, buying an estimated $19.1M and bringing the position to 250,101 shares worth $22.6M. The position accounts for 0.03% of the portfolio, ranked #381.

Corient Private Wealth first reported a position in EW in Q4 2022 and has held it in 15 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Corient Private Wealth held 250,101 shares of Edwards Lifesciences worth $22.6M as of Q2 2026.
  • Corient Private Wealth bought 227,947 Edwards Lifesciences shares in Q2 2026, an estimated $19.1M.
  • Edwards Lifesciences made up 0.03% of Corient Private Wealth's portfolio in Q2 2026, its #381 holding.
  • Corient Private Wealth first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 15 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.